ID CLH2_HUMAN Reviewed; 1640 AA. AC P53675; B7Z7U5; Q14017; Q15808; Q15809; DT 01-OCT-1996, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1997, sequence version 2. DT 24-JAN-2024, entry version 207. DE RecName: Full=Clathrin heavy chain 2; DE AltName: Full=Clathrin heavy chain on chromosome 22; DE Short=CLH-22; GN Name=CLTCL1; Synonyms=CLH22, CLTCL, CLTD; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RC TISSUE=Fetal brain; RX PubMed=8733128; DOI=10.1093/hmg/5.5.617; RA Sirotkin H., Morrow B., Dasgupta R., Goldberg R., Patangali S.R., Shi G., RA Cannizzaro L., Shprintzen R., Weissman S., Kucherlapati R.; RT "Isolation of a new clathrin heavy chain gene with muscle-specific RT expression from the region commonly deleted in velo-cardio-facial RT syndrome."; RL Hum. Mol. Genet. 5:617-624(1996). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND NUCLEOTIDE SEQUENCE [MRNA] OF RP 1451-1640 (ISOFORM 2). RC TISSUE=Fetal brain, and Skeletal muscle; RX PubMed=8733129; DOI=10.1093/hmg/5.5.625; RA Kedra D., Peyrard M., Fransson I., Collins J.E., Dunham I., Roe B.A., RA Dumanski J.P.; RT "Characterization of a second human clathrin heavy chain polypeptide gene RT (CLH-22) from chromosome 22q11."; RL Hum. Mol. Genet. 5:625-631(1996). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND VARIANT LYS-691. RX PubMed=8844170; DOI=10.1006/geno.1996.0386; RA Long K.R., Trofatter J.A., Ramesh V., McCormick M.K., Buckler A.J.; RT "Cloning and characterization of a novel human clathrin heavy chain gene RT (CLTCL)."; RL Genomics 35:466-472(1996). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RC TISSUE=Testis; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [6] RP INTERACTION WITH AFTPH. RX PubMed=15758025; DOI=10.1091/mbc.e04-12-1077; RA Hirst J., Borner G.H., Harbour M., Robinson M.S.; RT "The aftiphilin/p200/gamma-synergin complex."; RL Mol. Biol. Cell 16:2554-2565(2005). RN [7] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=20068231; DOI=10.1126/scisignal.2000475; RA Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., RA Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.; RT "Quantitative phosphoproteomics reveals widespread full phosphorylation RT site occupancy during mitosis."; RL Sci. Signal. 3:RA3-RA3(2010). CC -!- FUNCTION: Clathrin is the major protein of the polyhedral coat of CC coated pits and vesicles. Two different adapter protein complexes link CC the clathrin lattice either to the plasma membrane or to the trans- CC Golgi network (By similarity). {ECO:0000250}. CC -!- SUBUNIT: Clathrin triskelions, composed of 3 heavy chains and 3 light CC chains, are the basic subunits of the clathrin coat (By similarity). In CC the presence of light chains, hub assembly is influenced by both the pH CC and the concentration of calcium (Probable). May interact with OCRL (By CC similarity). Interacts with AFTPH/aftiphilin (PubMed:15758025). CC {ECO:0000250|UniProtKB:Q00610, ECO:0000250|UniProtKB:Q68FD5, CC ECO:0000269|PubMed:15758025, ECO:0000305}. CC -!- INTERACTION: CC P53675; PRO_0000449631 [P0DTD1]: rep; Xeno; NbExp=3; IntAct=EBI-358826, EBI-25475920; CC -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle membrane {ECO:0000250}; CC Peripheral membrane protein {ECO:0000250}; Cytoplasmic side CC {ECO:0000250}. Membrane, coated pit {ECO:0000250}; Peripheral membrane CC protein {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Note=Cytoplasmic CC face of coated pits and vesicles. {ECO:0000250}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; Synonyms=Long, Brain; CC IsoId=P53675-1; Sequence=Displayed; CC Name=2; Synonyms=Short, Muscle; CC IsoId=P53675-2; Sequence=VSP_001100; CC -!- TISSUE SPECIFICITY: Maximal levels in skeletal muscle. High levels in CC heart and testis. Low expression detected in all other tissues. CC -!- DOMAIN: The C-terminal third of the heavy chains forms the hub of the CC triskelion. This region contains the trimerization domain and the CC light-chain binding domain involved in the assembly of the clathrin CC lattice. CC -!- DOMAIN: The N-terminal seven-bladed beta-propeller is formed by WD40- CC like repeats, and projects inward from the polyhedral outer clathrin CC coat. It constitutes a major protein-protein interaction node (By CC similarity). {ECO:0000250}. CC -!- SIMILARITY: Belongs to the clathrin heavy chain family. {ECO:0000305}. CC -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and CC Haematology; CC URL="https://atlasgeneticsoncology.org/gene/361/CLTCL1"; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; U41763; AAC50494.1; -; mRNA. DR EMBL; X95486; CAA64752.1; -; mRNA. DR EMBL; X95487; CAA64753.1; -; mRNA. DR EMBL; U60802; AAB40908.1; -; mRNA. DR EMBL; U60803; AAB40909.1; -; mRNA. DR EMBL; AK302506; BAH13731.1; -; mRNA. DR EMBL; CH471176; EAX03047.1; -; Genomic_DNA. DR CCDS; CCDS46662.2; -. [P53675-1] DR CCDS; CCDS54497.2; -. [P53675-2] DR PIR; G02757; G02757. DR PIR; T09522; T09522. DR RefSeq; NP_001826.3; NM_001835.3. [P53675-2] DR RefSeq; NP_009029.3; NM_007098.3. [P53675-1] DR AlphaFoldDB; P53675; -. DR SMR; P53675; -. DR BioGRID; 113854; 228. DR IntAct; P53675; 71. DR MINT; P53675; -. DR STRING; 9606.ENSP00000441158; -. DR MoonDB; P53675; Curated. DR TCDB; 8.A.137.1.2; the clathrin (clathrin) family. DR GlyGen; P53675; 3 sites, 1 O-linked glycan (1 site). DR iPTMnet; P53675; -. DR MetOSite; P53675; -. DR PhosphoSitePlus; P53675; -. DR SwissPalm; P53675; -. DR BioMuta; CLTCL1; -. DR DMDM; 2506298; -. DR EPD; P53675; -. DR jPOST; P53675; -. DR MassIVE; P53675; -. DR MaxQB; P53675; -. DR PaxDb; 9606-ENSP00000441158; -. DR PeptideAtlas; P53675; -. DR ProteomicsDB; 56608; -. [P53675-1] DR ProteomicsDB; 56609; -. [P53675-2] DR Pumba; P53675; -. DR Antibodypedia; 50558; 139 antibodies from 21 providers. DR DNASU; 8218; -. DR Ensembl; ENST00000427926.6; ENSP00000441158.1; ENSG00000070371.16. [P53675-1] DR Ensembl; ENST00000621271.4; ENSP00000485020.1; ENSG00000070371.16. [P53675-2] DR GeneID; 8218; -. DR KEGG; hsa:8218; -. DR MANE-Select; ENST00000427926.6; ENSP00000441158.1; NM_007098.4; NP_009029.3. DR UCSC; uc032qgb.2; human. [P53675-1] DR AGR; HGNC:2093; -. DR CTD; 8218; -. DR DisGeNET; 8218; -. DR GeneCards; CLTCL1; -. DR GeneReviews; CLTCL1; -. DR HGNC; HGNC:2093; CLTCL1. DR HPA; ENSG00000070371; Group enriched (skeletal muscle, testis, tongue). DR MalaCards; CLTCL1; -. DR MIM; 601273; gene. DR neXtProt; NX_P53675; -. DR OpenTargets; ENSG00000070371; -. DR Orphanet; 453510; Congenital insensitivity to pain with severe intellectual disability. DR PharmGKB; PA26619; -. DR VEuPathDB; HostDB:ENSG00000070371; -. DR eggNOG; KOG0985; Eukaryota. DR GeneTree; ENSGT00950000183166; -. DR InParanoid; P53675; -. DR OMA; HTRVMDY; -. DR OrthoDB; 5474327at2759; -. DR PhylomeDB; P53675; -. DR TreeFam; TF300059; -. DR PathwayCommons; P53675; -. DR Reactome; R-HSA-190873; Gap junction degradation. DR Reactome; R-HSA-196025; Formation of annular gap junctions. DR Reactome; R-HSA-3928665; EPH-ephrin mediated repulsion of cells. DR Reactome; R-HSA-8856825; Cargo recognition for clathrin-mediated endocytosis. DR Reactome; R-HSA-8856828; Clathrin-mediated endocytosis. DR SignaLink; P53675; -. DR SIGNOR; P53675; -. DR BioGRID-ORCS; 8218; 29 hits in 1164 CRISPR screens. DR ChiTaRS; CLTCL1; human. DR GenomeRNAi; 8218; -. DR Pharos; P53675; Tbio. DR PRO; PR:P53675; -. DR Proteomes; UP000005640; Chromosome 22. DR RNAct; P53675; Protein. DR Bgee; ENSG00000070371; Expressed in gastrocnemius and 133 other cell types or tissues. DR ExpressionAtlas; P53675; baseline and differential. DR GO; GO:0030130; C:clathrin coat of trans-Golgi network vesicle; IEA:InterPro. DR GO; GO:0071439; C:clathrin complex; IBA:GO_Central. DR GO; GO:0045334; C:clathrin-coated endocytic vesicle; IBA:GO_Central. DR GO; GO:0005905; C:clathrin-coated pit; IDA:UniProtKB. DR GO; GO:0030136; C:clathrin-coated vesicle; IDA:UniProtKB. DR GO; GO:0030135; C:coated vesicle; IDA:UniProtKB. DR GO; GO:0005829; C:cytosol; TAS:Reactome. DR GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB. DR GO; GO:0005770; C:late endosome; IDA:UniProtKB. DR GO; GO:0016020; C:membrane; HDA:UniProtKB. DR GO; GO:0097443; C:sorting endosome; IDA:UniProtKB. DR GO; GO:0005819; C:spindle; IDA:UniProtKB. DR GO; GO:0005802; C:trans-Golgi network; IDA:UniProtKB. DR GO; GO:0032051; F:clathrin light chain binding; IBA:GO_Central. DR GO; GO:0005198; F:structural molecule activity; IEA:InterPro. DR GO; GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc. DR GO; GO:0006886; P:intracellular protein transport; IEA:InterPro. DR GO; GO:0000278; P:mitotic cell cycle; IDA:UniProtKB. DR GO; GO:0046326; P:positive regulation of glucose import; IMP:UniProtKB. DR GO; GO:0006898; P:receptor-mediated endocytosis; IDA:UniProtKB. DR GO; GO:0042147; P:retrograde transport, endosome to Golgi; IMP:UniProtKB. DR Gene3D; 1.25.40.730; -; 1. DR Gene3D; 2.130.10.110; Clathrin heavy-chain terminal domain; 1. DR Gene3D; 1.25.40.10; Tetratricopeptide repeat domain; 4. DR InterPro; IPR016024; ARM-type_fold. DR InterPro; IPR000547; Clathrin_H-chain/VPS_repeat. DR InterPro; IPR015348; Clathrin_H-chain_linker_core. DR InterPro; IPR016025; Clathrin_H-chain_N. DR InterPro; IPR022365; Clathrin_H-chain_propeller_rpt. DR InterPro; IPR016341; Clathrin_heavy_chain. DR InterPro; IPR011990; TPR-like_helical_dom_sf. DR PANTHER; PTHR10292:SF6; CLATHRIN HEAVY CHAIN 2; 1. DR PANTHER; PTHR10292; CLATHRIN HEAVY CHAIN RELATED; 1. DR Pfam; PF00637; Clathrin; 7. DR Pfam; PF09268; Clathrin-link; 1. DR Pfam; PF13838; Clathrin_H_link; 1. DR Pfam; PF01394; Clathrin_propel; 5. DR PIRSF; PIRSF002290; Clathrin_H_chain; 1. DR SMART; SM00299; CLH; 7. DR SUPFAM; SSF48371; ARM repeat; 6. DR SUPFAM; SSF50989; Clathrin heavy-chain terminal domain; 1. DR PROSITE; PS50236; CHCR; 7. DR Genevisible; P53675; HS. PE 1: Evidence at protein level; KW Acetylation; Alternative splicing; Coated pit; Cytoplasmic vesicle; KW Membrane; Phosphoprotein; Reference proteome; Repeat. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0000250|UniProtKB:Q00610" FT CHAIN 2..1640 FT /note="Clathrin heavy chain 2" FT /id="PRO_0000205786" FT REPEAT 537..683 FT /note="CHCR 1" FT REPEAT 686..828 FT /note="CHCR 2" FT REPEAT 833..972 FT /note="CHCR 3" FT REPEAT 979..1124 FT /note="CHCR 4" FT REPEAT 1128..1269 FT /note="CHCR 5" FT REPEAT 1274..1420 FT /note="CHCR 6" FT REPEAT 1423..1566 FT /note="CHCR 7" FT REGION 2..479 FT /note="Globular terminal domain" FT REGION 24..67 FT /note="WD40-like repeat 1" FT REGION 68..107 FT /note="WD40-like repeat 2" FT REGION 108..149 FT /note="WD40-like repeat 3" FT REGION 150..195 FT /note="WD40-like repeat 4" FT REGION 196..257 FT /note="WD40-like repeat 5" FT REGION 258..301 FT /note="WD40-like repeat 6" FT REGION 302..330 FT /note="WD40-like repeat 7" FT REGION 449..465 FT /note="Binding site for the uncoating ATPase, involved in FT lattice disassembly" FT /evidence="ECO:0000255" FT REGION 480..523 FT /note="Flexible linker" FT REGION 524..1640 FT /note="Heavy chain arm" FT REGION 524..634 FT /note="Distal segment" FT REGION 639..1640 FT /note="Proximal segment" FT REGION 1213..1522 FT /note="Involved in binding clathrin light chain" FT /evidence="ECO:0000250" FT REGION 1551..1640 FT /note="Trimerization" FT /evidence="ECO:0000250" FT MOD_RES 2 FT /note="N-acetylalanine" FT /evidence="ECO:0000250|UniProtKB:Q00610" FT MOD_RES 67 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q00610" FT MOD_RES 184 FT /note="Phosphotyrosine" FT /evidence="ECO:0000250|UniProtKB:Q68FD5" FT MOD_RES 394 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:Q00610" FT MOD_RES 634 FT /note="Phosphotyrosine" FT /evidence="ECO:0000250|UniProtKB:Q00610" FT MOD_RES 737 FT /note="N6-succinyllysine" FT /evidence="ECO:0000250|UniProtKB:Q68FD5" FT MOD_RES 856 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:Q00610" FT MOD_RES 899 FT /note="Phosphotyrosine" FT /evidence="ECO:0000250|UniProtKB:Q68FD5" FT MOD_RES 1167 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q68FD5" FT MOD_RES 1206 FT /note="Phosphotyrosine" FT /evidence="ECO:0000250|UniProtKB:Q68FD5" FT MOD_RES 1229 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q00610" FT MOD_RES 1441 FT /note="N6-acetyllysine; alternate" FT /evidence="ECO:0000250|UniProtKB:Q00610" FT MOD_RES 1441 FT /note="N6-succinyllysine; alternate" FT /evidence="ECO:0000250|UniProtKB:Q68FD5" FT MOD_RES 1477 FT /note="Phosphotyrosine" FT /evidence="ECO:0000250|UniProtKB:Q00610" FT MOD_RES 1487 FT /note="Phosphotyrosine" FT /evidence="ECO:0000250|UniProtKB:Q68FD5" FT MOD_RES 1494 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q00610" FT MOD_RES 1501 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:Q00610" FT VAR_SEQ 1479..1535 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:14702039, FT ECO:0000303|PubMed:8733129, ECO:0000303|PubMed:8844170" FT /id="VSP_001100" FT VARIANT 61 FT /note="P -> L (in dbSNP:rs3747059)" FT /id="VAR_055653" FT VARIANT 205 FT /note="K -> R (in dbSNP:rs5746697)" FT /id="VAR_055654" FT VARIANT 279 FT /note="Y -> C (in dbSNP:rs807459)" FT /id="VAR_055655" FT VARIANT 691 FT /note="E -> K (in dbSNP:rs1060374)" FT /evidence="ECO:0000269|PubMed:8844170" FT /id="VAR_055656" FT VARIANT 941 FT /note="K -> R (in dbSNP:rs35398725)" FT /id="VAR_055657" FT VARIANT 945 FT /note="R -> H (in dbSNP:rs36077768)" FT /id="VAR_055658" FT VARIANT 1046 FT /note="R -> C (in dbSNP:rs712952)" FT /id="VAR_055659" FT VARIANT 1195 FT /note="N -> S (in dbSNP:rs807547)" FT /id="VAR_059214" FT VARIANT 1316 FT /note="M -> V (in dbSNP:rs1061325)" FT /id="VAR_059215" FT VARIANT 1394 FT /note="I -> T (in dbSNP:rs1633399)" FT /id="VAR_059216" FT VARIANT 1592 FT /note="V -> M (in dbSNP:rs2073738)" FT /id="VAR_059217" FT VARIANT 1620 FT /note="R -> H (in dbSNP:rs5748024)" FT /id="VAR_059218" FT CONFLICT 193 FT /note="P -> H (in Ref. 1; AAC50494)" FT /evidence="ECO:0000305" FT CONFLICT 215 FT /note="L -> H (in Ref. 1; AAC50494)" FT /evidence="ECO:0000305" FT CONFLICT 320 FT /note="K -> T (in Ref. 2; CAA64752)" FT /evidence="ECO:0000305" FT CONFLICT 530 FT /note="L -> Q (in Ref. 1; AAC50494)" FT /evidence="ECO:0000305" FT CONFLICT 1474 FT /note="E -> K (in Ref. 3; AAB40908/AAB40909)" FT /evidence="ECO:0000305" FT CONFLICT 1620..1640 FT /note="RKQEEHVTEPAPLVFDFDGHE -> PPSKRSM (in Ref. 3; FT AAB40908/AAB40909)" FT /evidence="ECO:0000305" SQ SEQUENCE 1640 AA; 187030 MW; C661E1AB989D8E7F CRC64; MAQILPVRFQ EHFQLQNLGI NPANIGFSTL TMESDKFICI REKVGEQAQV TIIDMSDPMA PIRRPISAES AIMNPASKVI ALKAGKTLQI FNIEMKSKMK AHTMAEEVIF WKWVSVNTVA LVTETAVYHW SMEGDSQPMK MFDRHTSLVG CQVIHYRTDE YQKWLLLVGI SAQQNRVVGA MQLYSVDRKV SQPIEGHAAA FAEFKMEGNA KPATLFCFAV RNPTGGKLHI IEVGQPAAGN QPFVKKAVDV FFPPEAQNDF PVAMQIGAKH GVIYLITKYG YLHLYDLESG VCICMNRISA DTIFVTAPHK PTSGIIGVNK KGQVLSVCVE EDNIVNYATN VLQNPDLGLR LAVRSNLAGA EKLFVRKFNT LFAQGSYAEA AKVAASAPKG ILRTRETVQK FQSIPAQSGQ ASPLLQYFGI LLDQGQLNKL ESLELCHLVL QQGRKQLLEK WLKEDKLECS EELGDLVKTT DPMLALSVYL RANVPSKVIQ CFAETGQFQK IVLYAKKVGY TPDWIFLLRG VMKISPEQGL QFSRMLVQDE EPLANISQIV DIFMENSLIQ QCTSFLLDAL KNNRPAEGLL QTWLLEMNLV HAPQVADAIL GNKMFTHYDR AHIAQLCEKA GLLQQALEHY TDLYDIKRAV VHTHLLNPEW LVNFFGSLSV EDSVECLHAM LSANIRQNLQ LCVQVASKYH EQLGTQALVE LFESFKSYKG LFYFLGSIVN FSQDPDVHLK YIQAACKTGQ IKEVERICRE SSCYNPERVK NFLKEAKLTD QLPLIIVCDR FGFVHDLVLY LYRNNLQRYI EIYVQKVNPS RTPAVIGGLL DVDCSEEVIK HLIMAVRGQF STDELVAEVE KRNRLKLLLP WLESQIQEGC EEPATHNALA KIYIDSNNSP ECFLRENAYY DSSVVGRYCE KRDPHLACVA YERGQCDLEL IKVCNENSLF KSEARYLVCR KDPELWAHVL EETNPSRRQL IDQVVQTALS ETRDPEEISV TVKAFMTADL PNELIELLEK IVLDNSVFSE HRNLQNLLIL TAIKADRTRV MEYISRLDNY DALDIASIAV SSALYEEAFT VFHKFDMNAS AIQVLIEHIG NLDRAYEFAE RCNEPAVWSQ LAQAQLQKDL VKEAINSYIR GDDPSSYLEV VQSASRSNNW EDLVKFLQMA RKKGRESYIE TELIFALAKT SRVSELEDFI NGPNNAHIQQ VGDRCYEEGM YEAAKLLYSN VSNFARLAST LVHLGEYQAA VDNSRKASST RTWKEVCFAC MDGQEFRFAQ LCGLHIVIHA DELEELMCYY QDRGYFEELI LLLEAALGLE RAHMGMFTEL AILYSKFKPQ KMLEHLELFW SRVNIPKVLR AAEQAHLWAE LVFLYDKYEE YDNAVLTMMS HPTEAWKEGQ FKDIITKVAN VELCYRALQF YLDYKPLLIN DLLLVLSPRL DHTWTVSFFS KAGQLPLVKP YLRSVQSHNN KSVNEALNHL LTEEEDYQGL RASIDAYDNF DNISLAQQLE KHQLMEFRCI AAYLYKGNNW WAQSVELCKK DHLYKDAMQH AAESRDAELA QKLLQWFLEE GKRECFAACL FTCYDLLRPD MVLELAWRHN LVDLAMPYFI QVMREYLSKV DKLDALESLR KQEEHVTEPA PLVFDFDGHE //